NAFLD is characterized by an excessive fat accumulation in the liver; the progression of this condition involves, among other pathways, the NRLP3-inflammasome complex [12,17]; we, therefore, measured NRLP3 and Caspase-1 mRNA expression. This evidence concerns the gene CASP1 and metabolic dysfunction-associated steatotic liver disease.